Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression

Stem Cells Translational Medicine

Volumn 4, Issue 10, 2015, Pages 1131-1143

  Doeppner, Thorsten R ^a   Herz, Josephine ^a   Görgens, André ^a   Schlechter, Jana ^a   Ludwig, Anna Kristin ^a   Radtke, Stefan ^a   Demiroschedji, Kyra ^a   Horn, Peter A ^a   Giebel, Bernd ^a   Hermann, Irk M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Adult stem cells; Angiogenesis; Cellular therapy; Clinical translation; Mesenchymal stem cells; Nervous system; Tissue regeneration

Indexed keywords

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; BEHAVIOR; BLOOD ANALYSIS; BRAIN INJURY; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL INFILTRATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EXOSOME; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHOCYTOPENIA; MALE; MESENCHYMAL STEM CELL; MOTOR COORDINATION; MOUSE; NATURAL KILLER CELL; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; T LYMPHOCYTE; ANIMAL; ANTIBODY SPECIFICITY; ATAXIA; BONE MARROW CELL; BRAIN; C57BL MOUSE; CELL MOTION; COMPLICATION; CONDITIONED MEDIUM; DISEASE MODEL; IMMUNOLOGY; INFARCTION, MIDDLE CEREBRAL ARTERY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; ROTAROD TEST; TRANSPLANTATION; ULTRASTRUCTURE;

CONDITIONED MEDIUM;

ANIMALS; ATAXIA; BRAIN; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; EXTRACELLULAR VESICLES; INFARCTION, MIDDLE CEREBRAL ARTERY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MYELOID CELLS; NERVE REGENERATION; ORGAN SPECIFICITY; RANDOM ALLOCATION; ROTAROD PERFORMANCE TEST;

EID: 84942162960     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2015-0078     Document Type: Article

References (70)

1. Bacigaluppi M, Pluchino S, Peruzzotti-Jametti L et al. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 2009;132:2239-2251.
2. Banerjee S, Williamson DA, Habib N et al. The potential benefit of stem cell therapy after stroke: An update. Vasc Health Risk Manag 2012;8:569-580.
3. Chen J, Li Y, Wang L et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001;32:1005-1011.
4. Dharmasaroja P. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke. J Clin Neurosci 2009;16:12-20.
5. Doeppner TR, Kaltwasser B, Teli MK et al. Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice. Cell Death Dis 2014;5:e1386.
6. Leong WK, Henshall TL, Arthur A et al. Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:177-187.
7. Schwarting S, Litwak S, Hao W et al. Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 2008;39:2867-2875.
8. Shen LH, Li Y, Chen J et al. One-year followup after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke 2007;38:2150-2156.
9. Shen LH, Li Y, Chen J et al. Therapeutic benefit of bone marrow stromal cells administered month after stroke. J Cereb Blood Flow Metab 2007;27:6-13.
10. Shen LH, Li Y, Chen J et al. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 2006;137:393-399.
11. Ukai R, Honmou O, Harada K et al. Mesenchymal stem cells derived from peripheral blood protects against ischemia. J Neurotrauma 2007;24:508-520.
12. Zheng W, Honmou O, Miyata K et al. Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia. Brain Res 2010;1310:8-16.
13. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007;213:341-347.
14. Bhasin A, Srivastava MV, Kumaran SS et al. Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc Dis Extra 2011;1:93-104.
15. Bhasin A, Srivastava MV, Mohanty S et al. Stem cell therapy: A clinical trial of stroke. Clin Neurol Neurosurg 2013;115:1003-1008.
16. Doeppner TR, Hermann DM. Stem cellbased treatments against stroke: Observations from human proof-of-concept studies and considerations regarding clinical applicability. Front Cell Neurosci 2014;8:357.
17. Honmou O, Houkin K, Matsunaga T et al. Intravenous administration of auto serumexpanded autologous mesenchymal stem cells in stroke. Brain 2011;134:1790-1807.
18. Savitz SI, Misra V, Kasam M et al. Intravenous autologous bone marrowmononuclear cells for ischemic stroke. Ann Neurol 2011;70:59-69.
19. England T, Martin P, Bath PM. Stem cells for enhancing recovery after stroke: A review. Int J Stroke 2009;4:101-110.
20. Hermann DM, Chopp M. Promoting brain remodelling and plasticity for stroke recovery: Therapeuticpromiseandpotential pitfalls of clinical translation. Lancet Neurol 2012;11:369-380.
21. Yoo SW, Kim SS, Lee SY et al. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp Mol Med 2008; 40:387-397.
22. Doeppner TR, Ewert TA, Tönges L et al. Transduction of neural precursor cells with TAT-heat shock protein 70 chaperone: Therapeutic potential against ischemic stroke after intrastriatal and systemic transplantation. STEM CELLS 2012;30:1297-1310.
23. Lee RH, Pulin AA, Seo MJ et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009;5:54-63.
24. Timmers L, Lim SK, Arslan F et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res (Amst) 2007;1:129-137.
25. Hsieh JY, Wang HW, Chang SJ et al. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One 2013;8:e72604.
26. Scheibe F, Klein O, Klose J et al. Mesenchymal stromal cells rescue cortical neurons from apoptotic cell death in an in vitro model of cerebral ischemia. Cell Mol Neurobiol 2012; 32:567-576.
27. Tate CC, Fonck C, McGrogan M et al. Human mesenchymal stromal cells and their derivative, SB623 cells, rescue neural cells via trophic support following in vitro ischemia. Cell Transplant 2010;19:973-984.
28. Cantaluppi V, Gatti S, Medica D et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemiareperfusion injury by micro RNA-dependent reprogramming of resident renal cells. Kidney Int 2012;82:412-427.
29. Gatti S, Bruno S, Deregibus MC et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusioninduced acute and chronic kidney injury. Nephrol Dial Transplant 2011;26:1474-1483.
30. Lai RC, Arslan F, Lee MM et al. Exosome secreted by MSC reduces myocardial ischemia/ reperfusion injury. Stem Cell Res (Amst) 2010;4: 214-222.
31. Li T, Yan Y, Wang B et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 2013;22:845-854.
32. Xin H, Li Y, Cui Y et al. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 2013;33:1711-1715.
33. Witwer KW, Buzás EI, Bemis LT et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2013;2:2.
34. Thery C, Amigorena S, Raposo G et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006;Chapter 3:Unit 3.22.
35. Valadi H, Ekström K, Bossios A et al. Exosome-mediated transfer of mRNAs and micro RNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9: 654-659.
36. Ludwig AK, Giebel B. Exosomes: Small vesicles participating in intercellular communication. Int J Biochem Cell Biol 2012;44:11-15.
37. Mitkari B, Kerkelä E, Nystedt J et al. Intraarterial infusion of human bonemarrow-derived mesenchymal stemcells results in transient localization in the brain after cerebral ischemia in rats. Exp Neurol 2013;239:158-162.
38. Janowski M, Lyczek A, Engels C et al. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab 2013;33:921-927.
39. Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res 2008;100:133-158.
40. Blum B, Benvenisty N. The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 2009;8:3822-3830.
41. Dlouhy BJ, Awe O, Rao RC et al. Autograftderived spinal cord mass following olfactory mucosal cell transplantationina spinal cordinjurypatient: Case report. J Neurosurg Spine 2014;21:618-622.
42. Kordelas L, Rebmann V, Ludwig AK et al. MSC-derived exosomes: A novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 2014;28:970-973.
43. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymalstem cells. Lancet 2004;363:1439-1441.
44. Sokolova V, Ludwig AK, Hornung S et al. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces 2011;87:146-150.
45. Doeppner TR, Kaltwasser B, Bähr M et al. Effects of neural progenitor cells on post-stroke neurological impairment-A detailed and comprehensive analysis of behavioral tests. Front Cell Neurosci 2014;8:338.
46. Lin TN, He YY, Wu G et al. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 1993;24:117-121.
47. Herz J, Hagen SI, Bergmüller E et al. Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responses. Neurobiol Dis 2014;62:456-468.
48. Macrez R, Ali C, Toutirais O et al. Stroke and the immunesystem: From pathophysiology to new therapeutic strategies. Lancet Neurol 2011;10:471-480.
49. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008;8:726-736.
50. Offner H, Subramanian S, Parker SM et al. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 2006;26:654-665.
51. Dirnagl U, Klehmet J, Braun JS et al. Stroke-induced immunodepression: Experimental evidence and clinical relevance. Stroke 2007; 38(Suppl):770-773.
52. Meisel C, Meisel A. Suppressing immunosuppression after stroke. N Engl J Med 2011; 365:2134-2136.
53. Meisel C, Schwab JM, Prass K et al. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005;6: 775-786.
54. Gelderblom M, Leypoldt F, Steinbach K et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009;40:1849-1857.
55. Chung DJ, Choi CB, Lee SH et al. Intraarterially delivered human umbilical cord bloodderived mesenchymal stem cells in canine cerebral ischemia. J Neurosci Res 2009;87: 3554-3567.
56. Honma T, Honmou O, Iihoshi S et al. Intravenous infusion of immortalized humanmesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol 2006;199:56-66.
57. Leu S, Lin YC, Yuen CM et al. Adiposederived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Transl Med 2010; 8:63.
58. Bliss TM, Andres RH, Steinberg GK. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010;37:275-283.
59. Doeppner TR, Hermann DM. Mesenchymal stem cells in the treatment of ischemic stroke: Progress and possibilities. Stem Cells Cloning 2010;3:157-163.
60. Onda T, Honmou O, Harada K et al. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab 2008;28:329-340.
61. Doeppner TR, Doehring M, Bretschneider E et al. Micro RNA-124 protects against focal cerebral ischemia via mechanisms involving Usp14-dependent REST degradation. Acta Neuropathol 2013;126:251-265.
62. Komatsu K, Honmou O, Suzuki J et al. Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Res 2010;1334:84-92.
63. Caplan AI, Correa D. The MSC: An injury drugstore. Cell Stem Cell 2011;9:11-15.
64. Pittenger M. Sleuthing the source of regeneration by MSCs. Cell Stem Cell 2009;5: 8-10.
65. van Koppen A, Joles JA, van Balkom BW et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One 2012;7:e38746.
66. Famakin BM. The immune response to acute focal cerebral ischemia and associated post-stroke immunodepression: A focused review. Aging Dis 2014;5:307-326.
67. Vogelgesang A, May VE, Grunwald U et al. Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One 2010;5:e8718.
68. Sheikh AM, Nagai A, Wakabayashi K et al. Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: Contribution of fractalkine and IL-5. Neurobiol Dis 2011;41:717-724.
69. Yoo SW, Chang DY, Lee HS et al. Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-b Neurobiol Dis 2013;58: 249-257.
70. Li W, Ren G, Huang Y et al. Mesenchymal stem cells: A double-edged sword in regulating immune responses. Cell Death Differ 2012;19: 1505-1513.